Skip to main content

Table 2 The prevalence of T2D-coexisting diseases in respondents with NI-T2D and non-diabetics classified by their amount (n)

From: Impact of type 2 diabetes treated with non-insulin medication and number of diabetes-coexisting diseases on EQ-5D-5 L index scores in the Finnish population

Number of coexisting diseases (n) Hypertension n (%) Hypercholesterolemia n (%) Musculoskeletal disorders n (%) Heart problems n (%) Sleep problems n (%) GI disorders n (%) Kidney disease n (%)
NI-T2D
 1 (97) 61 (62.9) 24 (24.7) 3 (3.1) 2 (2.1) 4 (4.1) 3 (3.1) 0 (0.0)
 2 (137) 115 (83.9) 106 (77.4) 16 (11.7) 18 (13.1) 12 (8.8) 7 (5.1) 0 (0.0)
 3 (122) 111 (91.0) 108 (88.5) 47 (38.5) 66 (54.1) 20 (16.4) 13 (10.7) 1 (0.8)
  ≥ 4 (63) 62 (98.4) 60 (95.2) 50 (79.4) 48 (76.2) 32 (50.8) 22 (34.9) 1 (1.6)
Non-diabetics
 1 (1184) 448 (37.8) 160 (13.5) 288 (24.3) 81 (6.8) 95 (8.0) 112 (9.5) 0 (0.0)
 2 (597) 390 (65.3) 291 (48.7) 212 (35.5) 112 (18.8) 106 (17.8) 81 (13.6) 2 (0.3)
 3 (312) 269 (86.2) 233 (74.7) 139 (44.6) 175 (56.1) 62 (19.9) 53 (17.0) 5 (1.6)
  ≥ 4 (111) 108 (97.3) 96 (86.5) 83 (74.8) 79 (71.2) 52 (46.8) 39 (35.1) 1 (0.9)
  1. GI Gastrointestinal